Mental health on the market: Biopower, psychiatry and the pharmaceutical industry

Abstract

Ovaj rad problematizira biomedicinski model psihičkih poremećaja i farmakoterapiju te ispituje ulogu psihijatrije u širenju definicije psihičkih poremećaja u kontekstu medikalizacije društva koju obilježava tretiranje nemedicinskih problema kao medicinskih. Upućuje se na dimenzije isprepletenosti psihičkog zdravlja i tržišta u neoliberalnom kapitalističkom društvu s idejom da je farmaceutska industrija značajan akter u medikalizaciji svakodnevnog života koja omogućuje maksimizaciju profita na dereguliranom tržištu lijekova. Također se u radu problematizira odnos normalnog i abnormalnog, društvena moć i pozadina psihijatrijskih dijagnoza te se kroz prizmu koncepta biomoći razmatra vršenje funkcije socijalne kontrole od strane psihijatrije i na koji su način ti procesi povezani s tržišnom logikom neoliberalizma.This paper problematizes the biomedical model of mental disorders, pharmacotherapy and questions the role of psychiatry in spreading the definition of mental disorders in the context of the medicalization of society which is characterized by the treatment of nonmedical as medical problems. The paper points to the dimensions of entanglement of mental health and the market in a neoliberal capitalist society with an idea that the pharmaceutical industry is an important agent in the medicalization of everyday life which enables a maximization of profit on a deregulated drug market. The relationship between the normal and the abnormal, the social power and the background of psychiatric diagnoses are also dealt with. The exercise of the function of social control on behalf of psychiatry and the ways in which these processes are related to a market logic of neoliberalism are seen through the prism of a biopower concept

    Similar works